Delivery Order N0018924DZ013-N6854624F3010
- Not listed
- On June 5, 2025, the Bureau of Medicine and Surgery (BUMED), a defense agency within the Department of the Navy, awarded a delivery order valued at $7,440 to Alere San Diego, Inc., doing business as Immunalysis Corporation, for oxycodone and oxymorphone reagent kits (Catalog Number 302UR-0500PSC, CD: 6550). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of June 12, 2025, and will be performed in Cleveland, Ohio. No set-aside designation was...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Alere San Diego, Inc., a subsidiary of Abbott Laboratories. The $15,624.00 firm-fixed-price delivery order is for the provision of oxycodone and oxymorphone reagent kits, which are used for drug testing and substance abuse screening. Alere San Diego, Inc., doing business as Immunalysis Corporation, specializes in developing and manufacturing immunoassay reagents and test...
- Alere San Diego, Inc., doing business as Immunalysis Corporation, was awarded a delivery order on June 1, 2025, by the Defense Health Agency to supply oxycodone urine immunoassay kits to Kimbrough Ambulatory Care Center at Fort Meade, Maryland. The contract is structured as a firm fixed-price delivery order with a ceiling value of $29,760 and an ultimate completion date of August 22, 2025. No set-aside designation was used in this award, indicating open competition. Alere San Diego, a subsidiary...
- This federal contract award was issued by the Defense Health Agency (DHA) to Alere San Diego, Inc., doing business as Immunalysis Corporation, a subsidiary of Abbott Laboratories. The $9,920.00 firm fixed-price delivery order is for the procurement of OXY IA KITS 302UR-0500 oxycodone and oxymorphone reagent test kits. The contract has a completion date of May 31, 2024 and was awarded on April 26, 2024 without any set-aside designation. Alere San Diego is a manufacturer of immunoassay reagents...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency to Alere San Diego, Inc. (a subsidiary of Abbott Laboratories) for the provision of oxycodone and oxymorphone reagent kits to be used at the Tripler Army Medical Center in Hawaii. The contract has a ceiling value of $33,728.00 and a completion date of August 19, 2025. No set-aside designation was used for this award. Alere San Diego, Inc. is a for-profit organization that specializes in the development, manufacture,...
- The U.S. Department of Defense (DoD) awarded a firm-fixed-price delivery order contract to Alere San Diego, Inc. dba Immunalysis Corporation, a subsidiary of Abbott Laboratories Inc., to provide immunoassay reagents and test kits. The $60,000.00 contract supports the DoD's substance abuse screening and detection programs, including for fentanyl, synthetic cannabinoids, and other illicit substances. Alere San Diego, a manufacturer of these products, has previously held prime and subcontract...
- Alere San Diego, Inc., doing business as Immunalysis Corporation, was awarded a firm fixed-price delivery order valued at $16,202.34 by the Bureau of Medicine and Surgery (BUMED), a component of the Department of the Navy, on August 22, 2025. The contract calls for delivery of 6-AM Reagent Kits, specialized immunoassay products used for drug testing and substance abuse screening applications within federal healthcare and military medical facilities. The work is to be performed at the...
- This federal contract award to Alere San Diego, Inc., doing business as Immunalysis Corporation, is for the delivery of OXYCODONE & OXYMORPHONE REAGENT KITS to the Defense Health Agency. The $29,760.00 firm fixed-price delivery order contract has an ultimate completion date of August 1, 2024. No set-aside designation was used. Immunalysis is a specialized manufacturer of immunoassay reagents and test kits for drug testing, primarily supporting federal agencies like the Department of Defense,...
- This is a firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the Department of the Navy, to Alere San Diego, Inc. (a subsidiary of Abbott Laboratories) for the provision of 6-AM Reagent Kits. The contract has a ceiling value of $8,266.50 and an ultimate completion date of March 12, 2025. No set-aside designation was used for this award. Alere San Diego, Inc. has provided similar immunoassay reagents and testing kits for drug and substance abuse...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $42,416.87 firm fixed price delivery order contract to Alere San Diego, Inc., DBA Immunalysis Corp, a subsidiary of Abbott Laboratories, for FENTANYL/NONFENTANYL IMMUNOASSY REAGENT. Performance will take place in San Diego, California with a completion date of May 19, 2021. The contract was awarded on May 11, 2021 without a set-aside designation. The reagents will support immunoassay drug testing programs for the Navy Bureau...
- N0018924DZ013Indefinite Delivery Contract
- N0018924DZ013-N6854624F3010Delivery Order
This is a delivery order awarded by the Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Alere San Diego, Inc. (DBA Immunalysis), a subsidiary of Abbott Laboratories Inc. The $7,440.00 firm fixed price contract is for the provision of an oxycodone and oxymorphone reagent kit. This delivery order is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract vehicle for fentanyl and norfentanyl immunoassay reagents and test kits to support clinical testing and substance abuse screening programs across the Navy, Army, and Defense Health Agency. The contract does not have a set-aside designation. Alere San Diego has a history of providing immunoassay products and technical services to federal agencies like the Departments of Defense, Transportation, Justice, and Veterans Affairs to detect illicit substances.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 3/13/24 |